Zenpep 5000 UNT / 27,000 UNT / 17,000 UNT Delayed Release Oral Capsule
RxNorm 861842
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 861842 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Zenpep 5000 UNT / 27,000 UNT / 17,000 UNT Delayed Release Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Amylase 27000 UNT / lipase 5000 UNT / protease 17000 UNT Delayed Release Oral Capsule [Zenpep]
(Atom ID: 12361194)
SY
Synonym (SY):
Zenpep (amylases 27,000 UNT / endopeptidases 17,000 UNT / lipase 5000 UNT) Delayed Release Oral Capsule
(Atom ID: 11844723)
SY
Synonym (SY):
Zenpep 5 (amylase 27,000 UNT / lipase 5000 UNT / protease 17,000 UNT) Delayed Release Oral Capsule
(Atom ID: 11844722)
SY
Synonym (SY):
Zenpep 5 Delayed Release Oral Capsule
(Atom ID: 6339295)
PSN
Prescribable Name (PSN):
Zenpep 5000 UNT / 27,000 UNT / 17,000 UNT Delayed Release Oral Capsule
(Atom ID: 6364980)
Patient Education
Lipase
What is it? Lipase is a compound involved in the break down of fats during digestion. It is found in many plants, animals, bacteria, and molds. Some people use lipase as a medicine.
Lipase is most commonly used for indigestion (dyspepsia), heartburn, and other gastrointestinal problems, but there is no good scientific evidence to support these uses.
Do not confuse lipase with pancreatic enzyme products. Pancreatic enzyme products contain multiple ingredients, including lipase. Some of these products are approved by the US FDA for digestion problems due to a disorder of the pancreas (pancreatic insufficiency).
[Learn More]
* Please review the disclaimer below.